Is Buying ProShares UltraPro Short Dow30 ETF Here a Winning Strategy? Option Traders Like The Stock

 Is Buying ProShares UltraPro Short Dow30 ETF Here a Winning Strategy? Option Traders Like The Stock

In today’s session ProShares UltraPro Short Dow30 ETF (SDOW) registered an unusually high (205) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the November, 2016 call, expecting serious SDOW increase. With 205 contracts traded and 804 open interest for the Nov, 16 contract, it seems this is a quite bullish bet. The option with symbol: SDOW161118C00017000 closed last at: $0.2 or 33.3% down. ProShares UltraPro Short Dow30 ETF (NYSEARCA:SDOW) has declined 19.62% since April 7, 2016 and is downtrending. It has underperformed by 24.40% the S&P500.

ProShares UltraPro Short Dow30 seeks daily investment results that correspond to three times (300%) the inverse (opposite) of the daily performance of the Dow Jones Industrial Average (the Index). The ETF has a market cap of $183.76 million. The Index is a price-weighted index maintained by editors of The Wall Street Journal. It currently has negative earnings. The Index includes 30 large-cap, United States stocks, excluding utility and transportation companies.

More notable recent ProShares UltraPro Short Dow30 ETF (NYSEARCA:SDOW) news were published by: Zacks.com which released: “7 Inverse/Leveraged ETFs to Buy as Markets Make Way for Trump” on November 09, 2016, also Etftrends.com with their article: “Inverse ETFs Step into the Limelight” published on January 07, 2016, Marketwatch.com published: “ProShares UltraPro Short Dow30” on June 16, 2010. More interesting news about ProShares UltraPro Short Dow30 ETF (NYSEARCA:SDOW) were released by: Investorplace.com and their article: “Buying the Right Leveraged ETF (FAZ, BGU, DOG, SDOW, RFL, UYG)” published on April 21, 2010 as well as Etftrends.com‘s news article titled: “Inverse Stock ETFs to Hedge Further Pain” with publication date: August 21, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment